Sutro Biopharma Lays Off Dozens of Employees in Strategic Review
SOURCENews reportView the filing ↗
What we know
Based on news reporting.
Summary
Sutro Biopharma, Inc. has laid off approximately 36 employees as part of a strategic portfolio review. This decision reflects the company's ongoing efforts to streamline operations and focus on its core business areas. The layoffs are part of a broader initiative to enhance efficiency and align resources with strategic goals. While the specific departments affected were not disclosed, this move indicates a significant shift in the company's operational strategy amidst a challenging market environment.
Sutro Biopharma, Inc. cut 36 jobs as of March 18, 2025.
That is roughly 36% of the 100 people Sutro Biopharma, Inc. employs.
LayoffTalk has tracked 6 layoff events at Sutro Biopharma, Inc. since March 2025, including 119 jobs documented in official WARN filings, with 4 additional events known from news reporting.
Comments (0)
Anonymous by default. Be kind — people reading this may be going through it right now.
No comments yet. Be the first to share your thoughts.
Affected by this?
Share your story anonymously — it helps others reading this feel less alone.
Share your story →More layoffs at Sutro Biopharma, Inc.
Recent tracked events at this company.